1. Home
  2. BCO vs APLS Comparison

BCO vs APLS Comparison

Compare BCO & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCO
  • APLS
  • Stock Information
  • Founded
  • BCO 1859
  • APLS 2009
  • Country
  • BCO United States
  • APLS United States
  • Employees
  • BCO N/A
  • APLS N/A
  • Industry
  • BCO Oil Refining/Marketing
  • APLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BCO Consumer Discretionary
  • APLS Health Care
  • Exchange
  • BCO Nasdaq
  • APLS Nasdaq
  • Market Cap
  • BCO 4.1B
  • APLS 4.4B
  • IPO Year
  • BCO N/A
  • APLS 2017
  • Fundamental
  • Price
  • BCO $91.83
  • APLS $33.21
  • Analyst Decision
  • BCO Strong Buy
  • APLS Buy
  • Analyst Count
  • BCO 3
  • APLS 19
  • Target Price
  • BCO $120.50
  • APLS $49.89
  • AVG Volume (30 Days)
  • BCO 304.2K
  • APLS 3.2M
  • Earning Date
  • BCO 11-06-2024
  • APLS 11-05-2024
  • Dividend Yield
  • BCO 1.07%
  • APLS N/A
  • EPS Growth
  • BCO N/A
  • APLS N/A
  • EPS
  • BCO 2.64
  • APLS N/A
  • Revenue
  • BCO $4,993,300,000.00
  • APLS $715,216,000.00
  • Revenue This Year
  • BCO $3.72
  • APLS $95.53
  • Revenue Next Year
  • BCO $4.41
  • APLS $12.94
  • P/E Ratio
  • BCO $34.52
  • APLS N/A
  • Revenue Growth
  • BCO 3.60
  • APLS 162.10
  • 52 Week Low
  • BCO $79.03
  • APLS $24.34
  • 52 Week High
  • BCO $115.91
  • APLS $73.80
  • Technical
  • Relative Strength Index (RSI)
  • BCO 32.36
  • APLS 53.75
  • Support Level
  • BCO $93.96
  • APLS $32.88
  • Resistance Level
  • BCO $97.22
  • APLS $35.71
  • Average True Range (ATR)
  • BCO 2.32
  • APLS 1.60
  • MACD
  • BCO -0.22
  • APLS -0.22
  • Stochastic Oscillator
  • BCO 4.73
  • APLS 36.62

About BCO Brinks Company (The)

The Brink's Co is a Global provider of secure logistics and security solutions for cash and other valuables. In 2020, the company acquired the U.K.-based G4S that reorganized its operating segments to be North America, Latin America, Europe, and Rest of World. It generates maximum revenue from the North America segment, namely from its core business of cash-in-transit and ATM services. The Latin America and Europe segments trail North America in revenue earnings with the Brinks Global Services line of business that specializes in the secure transportation of high-valued commodities, such as jewelry, precious metals, banknotes, and electronics. Brink's customer base includes financial institutions, retails, government agencies, mints, and other commercial businesses.

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Share on Social Networks: